Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

In today's digital age, brands are facing increasing pressure to be transparent. Recent incidents, like the Air India crash ...

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of ...

Mens der bygges for 8,5 milliarder kroner på Novos byggeplads i Odense, har et falkepar haft gang i et noget mindre ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Brugere af Wegovy sparer op mod 2600 kroner på indkøb, viser beregning. Men det er ikke nødvendigvis et problem for ...

In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...

The foundation behind Novo Nordisk, which makes weight-loss drugs Ozempic and Wegovy, will invest €80 million ($93 million) ...